| Authors: |
Vaccaro CA; Programa de Cáncer Hereditario (ProCanHe), Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. carlos.vaccaro@hospitalitaliano.org.ar., Sarroca C; Uruguayan Collaborative Group, Hospital Militar, Montevideo, Uruguay., Rossi B; Brazilian Study Group on Hereditary Tumors - GETH, São Paulo, Brazil., Lopez-Kostner F; Clínica Las Condes, Santiago de Chile, Chile., Dominguez M; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo, Norway.; Department of Informatics, University of Oslo, Oslo, Norway., Calo NC; Programa de Cáncer Hereditario (ProCanHe), Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Cutait R; Hospital Sírio-Libanês, São Paulo, Brazil., Valle AD; Uruguayan Collaborative Group, Hospital Militar, Montevideo, Uruguay., Nuñez L; Instituto Nacional de Cáncer, Buenos Aires, Argentina., Neffa F; Uruguayan Collaborative Group, Hospital Militar, Montevideo, Uruguay., Alvarez K; Clínica Las Condes, Santiago de Chile, Chile., Gonzalez ML; Programa de Cáncer Hereditario (ProCanHe), Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Kalfayan P; Programa de Cáncer Hereditario (ProCanHe), Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Lynch HT; Creighton University, Omaha, NE, USA., Church J; Cleveland Clinic Foundation, Cleveland, OH, USA. |
